Karolis Rosickas, CEO
Sydney, Australia
Regeneus is a clinical-stage regenerative medicine company using stem cell technologies to develop a portfolio of novel cell-based therapies to address unmet medical needs in human health markets with a focus on neuropathic pain, including osteoarthritis and various skin conditions, with its platform technologies Progenza and Sygenus.

By using this website you agree to accept our Privacy Policy and Terms & Conditions